High-Dose Ursodeoxycholic Acid in Primary Sclerosing Cholangitis: A 5-Year Multicenter, Randomized, Controlled Study
Rolf Olsson, Kirsten Muri Boberg, Ove B. Schaffalitzky de Muckadell et al. · Gastroenterology · 2005
Cited by 395 works. doi:10.1053/j.gastro.2005.08.017
Authors
- Rolf Olsson
- Kirsten Muri Boberg
- Ove B. Schaffalitzky de Muckadell
- Stefan C. Lindgren
- Rolf W. Hultcrantz
- Geir Folvik
- Helge Bell
- Magnhild Gangsøy Kristiansen
- Jon Matre
- Andreas Rydning
- Ola Wikman
- Åke Danielsson
- Hanna Sandberg–Gertzén
- Kjell–Arne Ung
- Anders Eriksson
- Lars Lööf
- Hanne Prytz
- Hanns–Ulrich Marschall
- Ulrika Broomé
References
- The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.
- The MOS 36-ltem Short-Form Health Survey (SF-36)
- IS URSODEOXYCHOLIC ACID AN EFFECTIVE TREATMENT FOR PRIMARY BILIARY CIRRHOSIS?
- Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis.
- Ursodiol for Primary Sclerosing Cholangitis
- Hepatic and extrahepatic malignancies in primary sclerosing cholangitis
- Prevalence of Primary Sclerosing Cholangitis in Patients With Ulcerative Colitis
- Ursodeoxycholic Acid for Treatment of Primary Sclerosing Cholangitis: A Placebo–Controlled Trial
- Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis
- Health-related quality of life in chronic liver disease: the impact of type and severity of disease